[go: up one dir, main page]

FR3064473B1 - Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale - Google Patents

Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale Download PDF

Info

Publication number
FR3064473B1
FR3064473B1 FR1752864A FR1752864A FR3064473B1 FR 3064473 B1 FR3064473 B1 FR 3064473B1 FR 1752864 A FR1752864 A FR 1752864A FR 1752864 A FR1752864 A FR 1752864A FR 3064473 B1 FR3064473 B1 FR 3064473B1
Authority
FR
France
Prior art keywords
balance
skin
microbial flora
protective ingredient
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1752864A
Other languages
English (en)
Other versions
FR3064473A1 (fr
Inventor
Isabelle Bonnet
Louis Danoux
Manon Gault
Sabrina Leoty-Okombi
Boris Vogelgesang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR1752864A priority Critical patent/FR3064473B1/fr
Priority to PCT/FR2018/050801 priority patent/WO2018185408A1/fr
Publication of FR3064473A1 publication Critical patent/FR3064473A1/fr
Application granted granted Critical
Publication of FR3064473B1 publication Critical patent/FR3064473B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/719Pullulans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une nouvelle utilisation du pullulan ou d'un de ses dérivés ou de son association avec un polysaccharide choisi parmi l'acide hyaluronique, un de ses sels ou dérivés, l'acide alginique, un de ses sels ou dérivés et un mélange de ces polysaccharides pour maintenir et/ou préserver l'équilibre de la flore microbienne cutanée et/ou mucosale.
FR1752864A 2017-04-03 2017-04-03 Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale Active FR3064473B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1752864A FR3064473B1 (fr) 2017-04-03 2017-04-03 Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
PCT/FR2018/050801 WO2018185408A1 (fr) 2017-04-03 2018-03-30 Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1752864 2017-04-03
FR1752864A FR3064473B1 (fr) 2017-04-03 2017-04-03 Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale

Publications (2)

Publication Number Publication Date
FR3064473A1 FR3064473A1 (fr) 2018-10-05
FR3064473B1 true FR3064473B1 (fr) 2021-02-12

Family

ID=58779213

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1752864A Active FR3064473B1 (fr) 2017-04-03 2017-04-03 Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale

Country Status (2)

Country Link
FR (1) FR3064473B1 (fr)
WO (1) WO2018185408A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3097436B1 (fr) 2019-06-24 2023-10-13 Oreal Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose
FR3101775A1 (fr) * 2019-10-15 2021-04-16 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmétique de la N-méthylglycine pour augmenter la diversité de la flore microbienne cutanée
MX2023000423A (es) * 2020-07-10 2023-02-09 Unilever Ip Holdings B V Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades.
JP2023549118A (ja) * 2020-11-20 2023-11-22 ロレアル ケラチン物質をケアするための組成物
FR3132023B1 (fr) 2022-01-25 2024-01-05 Basf Beauty Care Solutions France Sas Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence
CN116270368A (zh) * 2023-05-15 2023-06-23 天津悟空美容科技有限责任公司 一种抗痤疮化妆品及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200717A1 (de) * 2002-01-10 2003-07-31 Knoell Hans Forschung Ev Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen
JP3885204B2 (ja) * 2002-04-16 2007-02-21 株式会社Cac 細胞活性促進外用剤
FR2839451B1 (fr) * 2002-05-07 2006-05-05 Oreal Compose comprenant un polymere, un espaceur et un principe actif, composition contenant ce compose et utilisations
CN1772862A (zh) * 2004-11-11 2006-05-17 沙德成 水溶性的膜片香皂
US8778369B2 (en) * 2005-07-29 2014-07-15 Delaval Holding Ab Barrier film-forming compositions and methods of use
CA2654255A1 (fr) 2006-06-28 2008-01-03 Novozymes Biopolymer A/S Compositions contenant plusieurs fragments d'acide hyaluronique a usage cosmetique et medical
CN101524510A (zh) * 2008-03-07 2009-09-09 大连永兴生物医药孵化器有限公司 一种治疗痤疮的姜黄消痤凝胶膜剂
KR101144493B1 (ko) * 2009-11-27 2012-05-11 조선대학교산학협력단 저분자의 알지네이트, 후코이단 또는 은-알지네이트를 유효성분으로 함유하는 항균 화장료 조성물
FR2994387B1 (fr) * 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
CN105769605A (zh) * 2016-04-25 2016-07-20 武文博 含人体活性透明质酸或人体活性透明质酸盐的化妆品
CN105943417A (zh) * 2016-04-29 2016-09-21 佛山市芊茹化妆品有限公司 具有防治手足皲裂功效的护肤组合物和护肤霜
CN106491633A (zh) * 2016-10-21 2017-03-15 克灵美(天津)生物科技有限公司 一种生物相容性良好的抗微生物消毒剂

Also Published As

Publication number Publication date
WO2018185408A1 (fr) 2018-10-11
FR3064473A1 (fr) 2018-10-05

Similar Documents

Publication Publication Date Title
FR3064473B1 (fr) Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
MX2020009347A (es) Picolinamidas como fungicidas.
MX2017013533A (es) Composiciones de limpieza personal concentradas.
MX367204B (es) Métodos y composiciones de limpieza personal concentradas.
AR072271A1 (es) Composicion para el lavado de ropa
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
MX2016012690A (es) Piridin-2-carboxamidas 5,6-disustituidas como agonistas del receptor cannabinoide.
WO2018153508A3 (fr) Inhibiteurs de la sulfoximine glycosidase
MX369169B (es) Formulaciones de lubricante.
FR3061856B1 (fr) Utilisations therapeutiques d'une poudre d'insectes
EA202090068A1 (ru) Соединения, влияющие на синтез пигмента и их применение для лечения бактериальных заболеваний
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX390386B (es) Carotenoides microbianos que afectan la composicion de la microbiota intestinal
EA201992542A1 (ru) Фармацевтическая композиция для местного применения, содержащая, по меньшей мере, амитриптилин, для лечения периферической нейропатической боли
EA202092730A1 (ru) Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
MX2017013534A (es) Composiciones concentradas para la limipieza personal y usos.
EP4289412A3 (fr) Formulations cutanées topiques
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
FR3064474B1 (fr) Nouvel ingredient protecteur et/ou reparateur des phaneres
MX2020011002A (es) Combinacion que comprende inhibidor de hdac, inhibidor de lag-3 y un inhibidor de pd-1 o inhibidor de pd-l1 para el tratamiento del cancer.
EA201991655A1 (ru) Тиобензоимидазолы в качестве фунгицидов
BR112017011108A2 (pt) composições de cabelo contendo polímeros catiônicos
MX2016013475A (es) Extracto de aloe vera para composiciones para el cuidado personal.
MX387201B (es) Composiciones para el tratamiento contra infecciones.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20181005

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9